75092-37-4

Basic information

• Product Name: Acetamide, N-(1,3-dimethyl-1H-pyrazol-5-yl)-
• CAS NO: 75092-37-4
• Molecular Formula: C7H11N3O
• Molecular Weight: 153.184
• Mol File: 75092-37-4.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Acetamide, N-(1,3-dimethyl-1H-pyrazol-5-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-(1,3-dimethyl-1H-pyrazol-5-yl)-(75092-37-4)
• EPA Substance Registry System: Acetamide, N-(1,3-dimethyl-1H-pyrazol-5-yl)-(75092-37-4)

Safety Data

• Hazardous Substances Data: 75092-37-4(Hazardous Substances Data)

Upstream product

• 3524-32-1 5-Amino-1,3-dimethylpyrazole 
• 127-08-2 potassium acetate 
• 108-24-7 acetic anhydride 

Downstream Products

• 1590502-70-7 2-((1,3-dimethyl-1H-pyrazol-5-yl)(methyl)carbamoyl)benzendiazonium hydrogensulfate 
• 1590502-63-8 2-amino-N-(1,3-dimethyl-1H-pyrazol-5-yl)-N-methylbenzamide 
• 144169-54-0 N-(1,3-dimethyl-1H-pyrazol-5-yl)-N-methyl-2-nitrobenzamide 
• 1201935-16-1 2-[[2-[(2,5-dimethylpyrazol-3-yl)amino]-5-(trifluoromethyl)-4-pyridyl]amino]-N,6-dimethoxy-benzamide 
• 1201935-19-4 2-[[2-[(2,5-dimethylpyrazol-3-yl)amino]-5-(trifluoromethyl)-4-pyridyl]amino]-4-fluoro-N-methyl-benzamide 
• 1201934-93-1 2-[[2-[(2,5-dimethylpyrazol-3-yl)amino]-5-(trifluoromethyl)-4-pyridyl]amino]-6-methoxy-N-methyl-benzamide 

Relevant articles and documents

TRPML MODULATORS

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Two-directional approach for the rapid synthesis of 2,4-bis-aminoaryl pyridine derivatives

We have developed two different approaches in parallel to rapidly access 2,4-bis aminoaryl pyridine compounds from a common starting material. The C-4/C-2 approach uses palladium-mediated coupling reactions to sequentially functionalize C-4 and then C-2. An alternative C-2/C-4 route uses a regioselective SNAr reaction to first substitute at C-2 then subsequently at C-4 by a palladium-mediated reaction. Both approaches have been used successfully to provide a range of 2,4-bis-aminoaryl pyridine compounds.

NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS

The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.